C4 Therapeutics, Inc. · Brief

Next report

3 days

Nov 5 · before openest.Q3 FY26

Expected move

±6.6%implied · report alone

3.153.59

straddle ±18.9%

spot 3.37exp Nov 20ATM strike 3ATM straddle 0.75IV 113%

Oct 30 closereport share · term structure

Expected move

—≥ implied

Q2 FY26±20.6%▲+6.91%×0.33

quarterimplied−25%0+25%realized×

Q2 FY26±20.6%▲+6.91%×0.33

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2

6disclosed supplier and customer ties in SEC filingsSEC filings

146managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

23managers whose positions together make up four fifths of reported value13F · Jun 30 '26

4 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

CCCC report session

No linked exposure.

Oct 22impliedImplied move: ±22.1% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.